XM_040189480.1	chrI	3248545	3248545	chrI	3246957	3258999	-	XM_040189480.1	path1	Q9MYX0	Sodium-dependent serotonin transporter	5HT transporter;Solute carrier family 6 member 4;	 PF03491;PF00209;	 GO:0012505;GO:0010008;GO:0005925;GO:0005887;GO:0045121;GO:0043005;GO:0005886;GO:0098793;GO:0045202;GO:0051015;GO:0042802;GO:0046872;GO:0005326;GO:0050998;GO:0051378;GO:0005335;GO:0048854;GO:0071310;GO:0046621;GO:0045787;GO:0010628;GO:0090067;GO:0009636;GO:0051610;GO:0035176;GO:0035725;	  C:endomembrane system; C:endosome membrane; C:focal adhesion; C:integral component of plasma membrane; C:membrane raft; C:neuron projection; C:plasma membrane; C:presynapse; C:synapse;	  F:actin filament binding; F:identical protein binding; F:metal ion binding; F:neurotransmitter transmembrane transporter activity; F:nitric-oxide synthase binding; F:serotonin binding; F:serotonin:sodium symporter activity;	  P:brain morphogenesis; P:cellular response to organic substance; P:negative regulation of organ growth; P:positive regulation of cell cycle; P:positive regulation of gene expression; P:regulation of thalamus size; P:response to toxic substance; P:serotonin uptake; P:social behavior; P:sodium ion transmembrane transport;
XM_040174847.1	chrI	26604719	26604719	chrI	26526347	26680230	-	XM_040174847.1	path1	O15394 A8MQ06 B7Z841 Q7Z7F2	Neural cell adhesion molecule 2		 PF00041;PF07679;	 GO:0030424;GO:0016021;GO:0043005;GO:0016604;GO:0005886;GO:0042802;GO:0007413;GO:0007158;GO:0007608;	  C:axon; C:integral component of membrane; C:neuron projection; C:nuclear body; C:plasma membrane;	  F:identical protein binding;	  P:axonal fasciculation; P:neuron cell-cell adhesion; P:sensory perception of smell;
XM_040167321.1	chrII	8245408	8245408	chrII	8240052	8325974	+	XM_040167321.1	path1	P78333 B2R726 O60436 Q9BX27	Glypican-5		 PF01153;	 GO:0046658;GO:0009986;GO:0062023;GO:0005576;GO:0005615;GO:0005796;GO:0016021;GO:0043202;GO:0005886;GO:0016477;GO:0006024;GO:0006027;GO:0090263;GO:1905475;GO:0001523;	  C:anchored component of plasma membrane; C:cell surface; C:collagen-containing extracellular matrix; C:extracellular region; C:extracellular space; C:Golgi lumen; C:integral component of membrane; C:lysosomal lumen; C:plasma membrane;	 	  P:cell migration; P:glycosaminoglycan biosynthetic process; P:glycosaminoglycan catabolic process; P:positive regulation of canonical Wnt signaling pathway; P:regulation of protein localization to membrane; P:retinoid metabolic process;
XM_040170451.1	chrIII	2161292	2161292	chrIII	2153033	2163959	-	XM_040170451.1	path1	Q5VZ46 Q5VZ45 Q9HCF8	Uncharacterized protein KIAA1614		 PF15737;	 GO:0016324;GO:0005938;GO:0005634;GO:0005080;GO:0007098;GO:0007163;GO:0060341;	  C:apical plasma membrane; C:cell cortex; C:nucleus;	  F:protein kinase C binding;	  P:centrosome cycle; P:establishment or maintenance of cell polarity; P:regulation of cellular localization;
XM_040170453.1	chrIII	2161356	2161356	chrIII	2164111	2179317	+	XM_040170453.1	path1	Q4VGL6 B2RS13 Q69Z31	Roquin-1 {ECO:0000305}	Protein Sanroque {ECO:0000303|PubMed:23583642};RING finger and C3H zinc finger protein 1;RING finger and CCCH-type zinc finger domain-containing protein 1;	 PF18386;PF00642;PF13445;	 GO:0005737;GO:0010494;GO:0000932;GO:0003725;GO:0035198;GO:0003730;GO:0003729;GO:0035613;GO:0061630;GO:0004842;GO:0008270;GO:0061158;GO:0001782;GO:0071347;GO:0048535;GO:0046007;GO:0030889;GO:0002635;GO:2000320;GO:0045623;GO:0000956;GO:0000288;GO:0033962;GO:0061014;GO:1901224;GO:0010608;GO:0000209;GO:0010468;GO:0002634;GO:2000628;GO:0043488;GO:0050856;GO:0048536;GO:0043029;GO:0042098;GO:0050852;GO:0061470;GO:0006511;	  C:cytoplasm; C:cytoplasmic stress granule; C:P-body;	  F:double-stranded RNA binding; F:miRNA binding; F:mRNA 3'-UTR binding; F:mRNA binding; F:RNA stem-loop binding; F:ubiquitin protein ligase activity; F:ubiquitin-protein transferase activity; F:zinc ion binding;	  P:3'-UTR-mediated mRNA destabilization; P:B cell homeostasis; P:cellular response to interleukin-1; P:lymph node development; P:negative regulation of activated T cell proliferation; P:negative regulation of B cell proliferation; P:negative regulation of germinal center formation; P:negative regulation of T-helper 17 cell differentiation; P:negative regulation of T-helper cell differentiation; P:nuclear-transcribed mRNA catabolic process; P:nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay; P:P-body assembly; P:positive regulation of mRNA catabolic process; P:positive regulation of NIK/NF-kappaB signaling; P:posttranscriptional regulation of gene expression; P:protein polyubiquitination; P:regulation of gene expression; P:regulation of germinal center formation; P:regulation of miRNA metabolic process; P:regulation of mRNA stability; P:regulation of T cell receptor signaling pathway; P:spleen development; P:T cell homeostasis; P:T cell proliferation; P:T cell receptor signaling pathway; P:T follicular helper cell differentiation; P:ubiquitin-dependent protein catabolic process;
XM_040171825.1	chrIII	2318001	2318001	chrIII	2295392	2372855	+	XM_040171825.1	path1	P78333 B2R726 O60436 Q9BX27	Glypican-5		 PF01153;	 GO:0046658;GO:0009986;GO:0062023;GO:0005576;GO:0005615;GO:0005796;GO:0016021;GO:0043202;GO:0005886;GO:0016477;GO:0006024;GO:0006027;GO:0090263;GO:1905475;GO:0001523;	  C:anchored component of plasma membrane; C:cell surface; C:collagen-containing extracellular matrix; C:extracellular region; C:extracellular space; C:Golgi lumen; C:integral component of membrane; C:lysosomal lumen; C:plasma membrane;	 	  P:cell migration; P:glycosaminoglycan biosynthetic process; P:glycosaminoglycan catabolic process; P:positive regulation of canonical Wnt signaling pathway; P:regulation of protein localization to membrane; P:retinoid metabolic process;
XM_040170797.1	chrIII	7223409	7223409	chrIII	7216370	7227089	+	XM_040170797.1	path1	Q8N350 K7EJP2 O43385	Voltage-dependent calcium channel beta subunit-associated regulatory protein {ECO:0000305}		 	 GO:0030426;GO:0016021;GO:0005886;GO:0030141;GO:0030672;GO:0044325;GO:1903170;GO:0045955;GO:1901386;	  C:growth cone; C:integral component of membrane; C:plasma membrane; C:secretory granule; C:synaptic vesicle membrane;	  F:ion channel binding;	  P:negative regulation of calcium ion transmembrane transport; P:negative regulation of calcium ion-dependent exocytosis; P:negative regulation of voltage-gated calcium channel activity;
XM_040170816.1	chrIII	7223409	7223409	chrIII	7227539	7238726	-	XM_040170816.1	path1	Q0GGW5	Serine/threonine-protein kinase STK11 {ECO:0000250|UniProtKB:Q15831}	Liver kinase B1 homolog;	 PF00069;	 GO:0005737;GO:0005829;GO:0016020;GO:0005739;GO:0005634;GO:0005524;GO:0000287;GO:0002039;GO:0030295;GO:0019901;GO:0106310;GO:0004674;GO:0106311;GO:0032147;GO:0007050;GO:0006974;GO:0009267;GO:0030010;GO:0042593;GO:0072332;GO:0090090;GO:0030308;GO:0046777;GO:0006470;GO:0006468;GO:0001558;GO:0042493;GO:0010212;GO:0001944;	  C:cytoplasm; C:cytosol; C:membrane; C:mitochondrion; C:nucleus;	  F:ATP binding; F:magnesium ion binding; F:p53 binding; F:protein kinase activator activity; F:protein kinase binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;	  P:activation of protein kinase activity; P:cell cycle arrest; P:cellular response to DNA damage stimulus; P:cellular response to starvation; P:establishment of cell polarity; P:glucose homeostasis; P:intrinsic apoptotic signaling pathway by p53 class mediator; P:negative regulation of canonical Wnt signaling pathway; P:negative regulation of cell growth; P:protein autophosphorylation; P:protein dephosphorylation; P:protein phosphorylation; P:regulation of cell growth; P:response to drug; P:response to ionizing radiation; P:vasculature development;
XM_040171547.1	chrIII	7293905	7293905	chrIII	7291648	7296093	+	XM_040171547.1	path1	Q90WG1	Spindlin-Z		 PF02513;	 GO:0005634;GO:0007049;GO:0007276;	  C:nucleus;	 	  P:cell cycle; P:gamete generation;
XM_040171546.1	chrIII	7293905	7293905	chrIII	7291652	7296093	+	XM_040171546.1	path1	Q4V8J7	Spindlin-1	Spindlin1;	 PF02513;	 GO:0005829;GO:0005730;GO:0005654;GO:0005634;GO:0005819;GO:0003677;GO:0035064;GO:0006325;GO:0007276;GO:0051321;GO:0007275;GO:0045893;GO:0030177;GO:0006355;GO:0009303;GO:0016055;	  C:cytosol; C:nucleolus; C:nucleoplasm; C:nucleus; C:spindle;	  F:DNA binding; F:methylated histone binding;	  P:chromatin organization; P:gamete generation; P:meiotic cell cycle; P:multicellular organism development; P:positive regulation of transcription, DNA-templated; P:positive regulation of Wnt signaling pathway; P:regulation of transcription, DNA-templated; P:rRNA transcription; P:Wnt signaling pathway;
XM_040170673.1	chrIII	7499887	7499887	chrIII	7494488	7499547	+	XM_040170673.1	path1	Q91XE9 Q8BWS0	Cyclic AMP-responsive element-binding protein 3-like protein 3	Transcription factor CREB-H;	 PF00170;	 GO:0005829;GO:0005783;GO:0005789;GO:0016021;GO:0016020;GO:0005654;GO:0005634;GO:0035497;GO:0001228;GO:0000981;GO:0046982;GO:0042803;GO:0000978;GO:0000977;GO:0000976;GO:0030968;GO:0045944;GO:1990440;GO:0006357;	  C:cytosol; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of membrane; C:membrane; C:nucleoplasm; C:nucleus;	  F:cAMP response element binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:protein heterodimerization activity; F:protein homodimerization activity; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding; F:transcription regulatory region sequence-specific DNA binding;	  P:endoplasmic reticulum unfolded protein response; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress; P:regulation of transcription by RNA polymerase II;
XM_040172046.1	chrIII	7499887	7499887	chrIII	7502262	7504787	+	XM_040172046.1	path1	Q9NSD7 Q14DA5	Relaxin-3 receptor 1	G protein-coupled receptor SALPR;G-protein coupled receptor GPCR135;Relaxin family peptide receptor 3;Somatostatin- and angiotensin-like peptide receptor;	 PF00001;	 GO:0005887;GO:0005886;GO:0008528;GO:0004930;GO:0007186;GO:0007218;GO:0032467;	  C:integral component of plasma membrane; C:plasma membrane;	  F:G protein-coupled peptide receptor activity; F:G protein-coupled receptor activity;	  P:G protein-coupled receptor signaling pathway; P:neuropeptide signaling pathway; P:positive regulation of cytokinesis;
XM_040172047.1	chrIII	7499887	7499887	chrIII	7506046	7512245	-	XM_040172047.1	path1	Q8N6T7 B2RCD0 O75291 Q6IAF5 Q6PK99 Q8NCD2 Q9BSI5 Q9BWP3 Q9NRC7 Q9UQD1	NAD-dependent protein deacetylase sirtuin-6	Regulatory protein SIR2 homolog 6;SIR2-like protein 6;	 PF02146;	 GO:0099115;GO:0005737;GO:0005654;GO:0005634;GO:0019213;GO:0004407;GO:0003956;GO:0003950;GO:0070403;GO:0017136;GO:0046969;GO:0003714;GO:0008270;GO:0070932;GO:0000122;GO:1905555;GO:1902732;GO:0031940;GO:0120162;GO:1905549;GO:0032206;GO:1901485;GO:1905564;GO:0003247;GO:0006471;GO:0006476;GO:0010569;GO:0031667;	  C:chromosome, subtelomeric region; C:cytoplasm; C:nucleoplasm; C:nucleus;	  F:deacetylase activity; F:histone deacetylase activity; F:NAD(P)+-protein-arginine ADP-ribosyltransferase activity; F:NAD+ ADP-ribosyltransferase activity; F:NAD+ binding; F:NAD-dependent histone deacetylase activity; F:NAD-dependent histone deacetylase activity (H3-K9 specific); F:transcription corepressor activity; F:zinc ion binding;	  P:histone H3 deacetylation; P:negative regulation of transcription by RNA polymerase II; P:positive regulation of blood vessel branching; P:positive regulation of chondrocyte proliferation; P:positive regulation of chromatin silencing at telomere; P:positive regulation of cold-induced thermogenesis; P:positive regulation of subtelomeric heterochromatin assembly; P:positive regulation of telomere maintenance; P:positive regulation of transcription factor catabolic process; P:positive regulation of vascular endothelial cell proliferation; P:post-embryonic cardiac muscle cell growth involved in heart morphogenesis; P:protein ADP-ribosylation; P:protein deacetylation; P:regulation of double-strand break repair via homologous recombination; P:response to nutrient levels;
XM_040172049.1	chrIII	7534490	7534490	chrIII	7522944	7529342	-	XM_040172049.1	path1	Q9YHX4	Semaphorin-4E	Semaphorin-7;Semaphorin-Z7;	 PF01437;PF01403;	 GO:0005615;GO:0005887;GO:0045499;GO:0030215;GO:0007411;GO:0050919;GO:0010693;GO:0048843;GO:0000122;GO:0001755;GO:0043931;GO:0030335;GO:0043547;GO:0071526;	  C:extracellular space; C:integral component of plasma membrane;	  F:chemorepellent activity; F:semaphorin receptor binding;	  P:axon guidance; P:negative chemotaxis; P:negative regulation of alkaline phosphatase activity; P:negative regulation of axon extension involved in axon guidance; P:negative regulation of transcription by RNA polymerase II; P:neural crest cell migration; P:ossification involved in bone maturation; P:positive regulation of cell migration; P:positive regulation of GTPase activity; P:semaphorin-plexin signaling pathway;
XM_040172054.1	chrIII	7534490	7534490	chrIII	7529646	7534343	-	XM_040172054.1	path1	Q9UGK3 A6NKK3 Q9NXI2	Signal-transducing adaptor protein 2	Breast tumor kinase substrate;	 	 GO:0005829;GO:0005886;GO:0035591;GO:0042531;	  C:cytosol; C:plasma membrane;	  F:signaling adaptor activity;	  P:positive regulation of tyrosine phosphorylation of STAT protein;
XM_040172051.1	chrIII	7534490	7534490	chrIII	7534649	7543634	-	XM_040172051.1	path1	Q8AXV0	Endophilin-A2	Endophilin-2;SH3 domain-containing GRB2-like protein 2;SH3p8;	 PF03114;PF00018;	 GO:0030054;GO:0042995;GO:0031901;GO:0002102;GO:0008289;GO:0006897;	  C:cell junction; C:cell projection; C:early endosome membrane; C:podosome;	  F:lipid binding;	  P:endocytosis;
XM_040172180.1	chrIII	7534492	7534492	chrIII	7544336	7556424	-	XM_040172180.1	path1	Q92753 Q8WX73	Nuclear receptor ROR-beta	Nuclear receptor RZR-beta;Nuclear receptor subfamily 1 group F member 2;Retinoid-related orphan receptor-beta;	 PF00104;PF00105;	 GO:0000785;GO:0005654;GO:0005634;GO:0001228;GO:0003700;GO:0000981;GO:0008502;GO:0004879;GO:0000978;GO:1990837;GO:0008134;GO:0008270;GO:0035881;GO:0071300;GO:0042462;GO:0045668;GO:0045892;GO:0045944;GO:0045893;GO:0042752;GO:0006357;GO:0006355;GO:0060041;GO:0046549;GO:0046548;GO:0048511;GO:0006367;GO:0007601;	  C:chromatin; C:nucleoplasm; C:nucleus;	  F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:melatonin receptor activity; F:nuclear receptor activity; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding; F:transcription factor binding; F:zinc ion binding;	  P:amacrine cell differentiation; P:cellular response to retinoic acid; P:eye photoreceptor cell development; P:negative regulation of osteoblast differentiation; P:negative regulation of transcription, DNA-templated; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:regulation of circadian rhythm; P:regulation of transcription by RNA polymerase II; P:regulation of transcription, DNA-templated; P:retina development in camera-type eye; P:retinal cone cell development; P:retinal rod cell development; P:rhythmic process; P:transcription initiation from RNA polymerase II promoter; P:visual perception;
XM_040172186.1	chrIII	7562597	7562597	chrIII	7564006	7565723	+	XM_040172186.1	path1	Q9HC97 J3KR30 O43495 Q17R58 Q4VBN5 Q4ZFV2 Q6FHI8 Q86UH4	G-protein coupled receptor 35	Kynurenic acid receptor;	 PF00001;	 GO:0005887;GO:0005886;GO:0016494;GO:0004930;GO:0070098;GO:0007010;GO:0007186;GO:1904456;GO:1901386;GO:0007204;GO:0051482;GO:0035025;	  C:integral component of plasma membrane; C:plasma membrane;	  F:C-X-C chemokine receptor activity; F:G protein-coupled receptor activity;	  P:chemokine-mediated signaling pathway; P:cytoskeleton organization; P:G protein-coupled receptor signaling pathway; P:negative regulation of neuronal action potential; P:negative regulation of voltage-gated calcium channel activity; P:positive regulation of cytosolic calcium ion concentration; P:positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway; P:positive regulation of Rho protein signal transduction;
XM_040172177.1	chrIII	7562597	7562597	chrIII	7574165	7596301	-	XM_040172177.1	path1	O70141	Semaphorin-6B	Semaphorin-Z;	 PF01403;	 GO:0005615;GO:0005887;GO:0045499;GO:0030215;GO:0007411;GO:0007417;GO:0021766;GO:0050919;GO:0048843;GO:0001755;GO:0030335;GO:0071526;	  C:extracellular space; C:integral component of plasma membrane;	  F:chemorepellent activity; F:semaphorin receptor binding;	  P:axon guidance; P:central nervous system development; P:hippocampus development; P:negative chemotaxis; P:negative regulation of axon extension involved in axon guidance; P:neural crest cell migration; P:positive regulation of cell migration; P:semaphorin-plexin signaling pathway;
XM_040175423.1	chrIV	32584511	32584511	chrIV	32581888	32583675	-	XM_040175423.1	path1	Q90259	Achaete-scute homolog 1a	Pituitary-absent protein;	 PF00010;	 GO:0005634;GO:0090575;GO:0000981;GO:0046983;GO:0000977;GO:0043565;GO:0021984;GO:0031103;GO:0043697;GO:0048566;GO:0002070;GO:0021575;GO:0060575;GO:0010629;GO:0007399;GO:0030182;GO:0045666;GO:0045944;GO:0045893;GO:0031099;GO:0050767;GO:0006357;GO:0070654;GO:0007423;GO:0061549;GO:0061195;	  C:nucleus; C:RNA polymerase II transcription regulator complex;	  F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:protein dimerization activity; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding; F:sequence-specific DNA binding;	  P:adenohypophysis development; P:axon regeneration; P:cell dedifferentiation; P:embryonic digestive tract development; P:epithelial cell maturation; P:hindbrain morphogenesis; P:intestinal epithelial cell differentiation; P:negative regulation of gene expression; P:nervous system development; P:neuron differentiation; P:positive regulation of neuron differentiation; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:regeneration; P:regulation of neurogenesis; P:regulation of transcription by RNA polymerase II; P:sensory epithelium regeneration; P:sensory organ development; P:sympathetic ganglion development; P:taste bud formation;
XM_040175437.1	chrIV	32602258	32602258	chrIV	32595040	32608598	-	XM_040175437.1	path1	Q9JHR9 Q14BZ2 Q3U0V7 Q3UYH0	Nuclear receptor-interacting protein 2	Neuronal-interacting factor X 1;	 PF09668;	 GO:0005737;GO:0005634;GO:0004190;GO:0000122;GO:0007219;	  C:cytoplasm; C:nucleus;	  F:aspartic-type endopeptidase activity;	  P:negative regulation of transcription by RNA polymerase II; P:Notch signaling pathway;
XM_040174757.1	chrIV	32690154	32690154	chrIV	32681801	32696421	+	XM_040174757.1	path1	Q6ZV73 Q6ZR53 Q7Z2Z7 Q96D44 Q9NUR8 Q9P2I5	FYVE, RhoGEF and PH domain-containing protein 6	Zinc finger FYVE domain-containing protein 24;	 PF01363;PF00169;PF00621;	 GO:0005737;GO:0005856;GO:0005794;GO:0030027;GO:0001726;GO:0005085;GO:0046872;GO:0031267;GO:0030036;GO:0007010;GO:0046847;GO:0008360;GO:0043087;	  C:cytoplasm; C:cytoskeleton; C:Golgi apparatus; C:lamellipodium; C:ruffle;	  F:guanyl-nucleotide exchange factor activity; F:metal ion binding; F:small GTPase binding;	  P:actin cytoskeleton organization; P:cytoskeleton organization; P:filopodium assembly; P:regulation of cell shape; P:regulation of GTPase activity;
XM_040173973.1	chrIV	32779885	32779885	chrIV	32772105	32775753	+	XM_040173973.1	path1	Q95KK4	Single-stranded DNA-binding protein, mitochondrial		 PF00436;	 GO:0042645;GO:0003682;GO:0003697;GO:0006260;	  C:mitochondrial nucleoid;	  F:chromatin binding; F:single-stranded DNA binding;	  P:DNA replication;
XM_040173974.1	chrIV	32779885	32779885	chrIV	32776433	32793433	+	XM_040173974.1	path1	A1L224	Cyclic AMP-responsive element-binding protein 3-like protein 2		 PF00170;	 GO:0005783;GO:0005789;GO:0016021;GO:0005634;GO:0035497;GO:0000981;GO:0000976;GO:0051216;GO:0002062;GO:0030968;GO:0045944;GO:0060628;GO:0003330;GO:0006357;GO:0034976;	  C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of membrane; C:nucleus;	  F:cAMP response element binding; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:transcription regulatory region sequence-specific DNA binding;	  P:cartilage development; P:chondrocyte differentiation; P:endoplasmic reticulum unfolded protein response; P:positive regulation of transcription by RNA polymerase II; P:regulation of ER to Golgi vesicle-mediated transport; P:regulation of extracellular matrix constituent secretion; P:regulation of transcription by RNA polymerase II; P:response to endoplasmic reticulum stress;
XM_040187614.1	chrIX	871871	871871	chrIX	855692	903860	+	XM_040187614.1	path1	Q9R1L5 Q7TQG9 Q80TN0	Microtubule-associated serine/threonine-protein kinase 1	Syntrophin-associated serine/threonine-protein kinase;	 PF08926;PF17820;PF00069;	 GO:0030424;GO:0005737;GO:0005856;GO:0030425;GO:0016020;GO:0043005;GO:0043025;GO:0005886;GO:0005524;GO:0000287;GO:0008017;GO:0106310;GO:0004674;GO:0106311;GO:0007420;GO:0007010;GO:0035556;GO:0018105;GO:0006468;	  C:axon; C:cytoplasm; C:cytoskeleton; C:dendrite; C:membrane; C:neuron projection; C:neuronal cell body; C:plasma membrane;	  F:ATP binding; F:magnesium ion binding; F:microtubule binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;	  P:brain development; P:cytoskeleton organization; P:intracellular signal transduction; P:peptidyl-serine phosphorylation; P:protein phosphorylation;
XM_040187619.1	chrIX	908061	908061	chrIX	905367	912739	+	XM_040187619.1	path1	Q684M2	Cysteine protease ATG4D	Autophagin-4;Autophagy-related protein 4 homolog D;	 PF03416;	 GO:0005759;GO:0008234;GO:0006915;GO:0006914;GO:0015031;	  C:mitochondrial matrix;	  F:cysteine-type peptidase activity;	  P:apoptotic process; P:autophagy; P:protein transport;
XM_040187622.1	chrIX	911634	911634	chrIX	913920	928611	+	XM_040187622.1	path1	P51532 B1A8Z4 B1A8Z5 B1A8Z6 B1A8Z7 E9PBR8 O95052 Q9HBD3	Transcription activator BRG1	ATP-dependent helicase SMARCA4;BRG1-associated factor 190A;Mitotic growth and transcription activator;Protein BRG-1;Protein brahma homolog 1;SNF2-beta;SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily A member 4;	 PF07533;PF00439;PF00271;PF07529;PF08880;PF14619;PF00176;	 GO:0000785;GO:0005615;GO:0016020;GO:0071565;GO:0071564;GO:0005730;GO:0005654;GO:0005634;GO:0032991;GO:0016514;GO:0050681;GO:0005524;GO:0008094;GO:0003677;GO:0070182;GO:0004386;GO:0070577;GO:0070615;GO:0002039;GO:0047485;GO:0003723;GO:0030957;GO:0003713;GO:0003714;GO:0008134;GO:0043044;GO:1904837;GO:0006325;GO:0006338;GO:0038111;GO:0060766;GO:0030308;GO:0000122;GO:0045892;GO:0007399;GO:0003407;GO:0006337;GO:0043923;GO:0051091;GO:1902661;GO:1902895;GO:0045944;GO:1901838;GO:0045893;GO:0030177;GO:0006357;GO:0001188;	  C:chromatin; C:extracellular space; C:membrane; C:nBAF complex; C:npBAF complex; C:nucleolus; C:nucleoplasm; C:nucleus; C:protein-containing complex; C:SWI/SNF complex;	  F:androgen receptor binding; F:ATP binding; F:ATPase activity, acting on DNA; F:DNA binding; F:DNA polymerase binding; F:helicase activity; F:lysine-acetylated histone binding; F:nucleosome-dependent ATPase activity; F:p53 binding; F:protein N-terminus binding; F:RNA binding; F:Tat protein binding; F:transcription coactivator activity; F:transcription corepressor activity; F:transcription factor binding;	  P:ATP-dependent chromatin remodeling; P:beta-catenin-TCF complex assembly; P:chromatin organization; P:chromatin remodeling; P:interleukin-7-mediated signaling pathway; P:negative regulation of androgen receptor signaling pathway; P:negative regulation of cell growth; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:nervous system development; P:neural retina development; P:nucleosome disassembly; P:positive regulation by host of viral transcription; P:positive regulation of DNA-binding transcription factor activity; P:positive regulation of glucose mediated signaling pathway; P:positive regulation of pri-miRNA transcription by RNA polymerase II; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription of nucleolar large rRNA by RNA polymerase I; P:positive regulation of transcription, DNA-templated; P:positive regulation of Wnt signaling pathway; P:regulation of transcription by RNA polymerase II; P:RNA polymerase I preinitiation complex assembly;
XM_040186993.1	chrIX	996420	996420	chrIX	989250	991503	-	XM_040186993.1	path1	A0A087WSX0	Immunoglobulin lambda variable 5-45 {ECO:0000303|PubMed:11872955, ECO:0000303|Ref.3}		 PF07686;	 GO:0005615;GO:0019814;GO:0005886;GO:0002250;GO:0006955;	  C:extracellular space; C:immunoglobulin complex; C:plasma membrane;	 	  P:adaptive immune response; P:immune response;
XM_040175855.1	chrV	5684473	5684473	chrV	5675251	5706933	-	XM_040175855.1	path1	Q9QXY2 Q9QXY3	SRC kinase signaling inhibitor 1 {ECO:0000305}	SNAP-25-interacting protein;p130Cas-associated protein;p140Cap {ECO:0000303|PubMed:18662323};	 PF03915;	 GO:0015629;GO:0030424;GO:0005737;GO:0030425;GO:0030175;GO:0030027;GO:0043005;GO:0043025;GO:0014069;GO:0098793;GO:0045202;GO:0030234;GO:0019904;GO:0019901;GO:0006887;GO:0007162;GO:0050709;GO:0061099;GO:0061098;GO:0030334;GO:0061001;GO:0034446;	  C:actin cytoskeleton; C:axon; C:cytoplasm; C:dendrite; C:filopodium; C:lamellipodium; C:neuron projection; C:neuronal cell body; C:postsynaptic density; C:presynapse; C:synapse;	  F:enzyme regulator activity; F:protein domain specific binding; F:protein kinase binding;	  P:exocytosis; P:negative regulation of cell adhesion; P:negative regulation of protein secretion; P:negative regulation of protein tyrosine kinase activity; P:positive regulation of protein tyrosine kinase activity; P:regulation of cell migration; P:regulation of dendritic spine morphogenesis; P:substrate adhesion-dependent cell spreading;
XM_040178142.1	chrVI	8575838	8575838	chrVI	8570225	8574990	+	XM_040178142.1	path1	Q5E9R2 Q5EA78	1-acyl-sn-glycerol-3-phosphate acyltransferase delta	1-acylglycerol-3-phosphate O-acyltransferase 4;Lysophosphatidic acid acyltransferase delta;	 PF16076;PF01553;	 GO:0012505;GO:0005783;GO:0005789;GO:0016021;GO:0005741;GO:0003841;GO:0016746;GO:0016024;	  C:endomembrane system; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of membrane; C:mitochondrial outer membrane;	  F:1-acylglycerol-3-phosphate O-acyltransferase activity; F:transferase activity, transferring acyl groups;	  P:CDP-diacylglycerol biosynthetic process;
XM_040178137.1	chrVI	8575838	8575838	chrVI	8576382	8593045	-	XM_040178137.1	path1	Q9Y6R4 A6H8W0 B7ZLD3 B9EG75 Q5VTT8 Q5VTT9 Q92612 Q9H408	Mitogen-activated protein kinase kinase kinase 4	MAP three kinase 1;MAPK/ERK kinase kinase 4;	 PF00069;	 GO:0005737;GO:0048471;GO:0005524;GO:0004709;GO:0046872;GO:0106310;GO:0106311;GO:0000186;GO:0035556;GO:0043507;GO:1900745;GO:0051973;GO:1904355;GO:0032212;GO:0010225;	  C:cytoplasm; C:perinuclear region of cytoplasm;	  F:ATP binding; F:MAP kinase kinase kinase activity; F:metal ion binding; F:protein serine kinase activity; F:protein threonine kinase activity;	  P:activation of MAPKK activity; P:intracellular signal transduction; P:positive regulation of JUN kinase activity; P:positive regulation of p38MAPK cascade; P:positive regulation of telomerase activity; P:positive regulation of telomere capping; P:positive regulation of telomere maintenance via telomerase; P:response to UV-C;
XM_040178626.1	chrVI	16228670	16228670	chrVI	16183136	16400991	-	XM_040178626.1	path1	O35181	Pro-neuregulin-3, membrane-bound isoform		 	 GO:0005615;GO:0098978;GO:0016021;GO:0005886;GO:0045499;GO:0008083;GO:0005102;GO:0048513;GO:0021842;GO:0035556;GO:0030879;GO:0060596;GO:0050804;GO:2001223;GO:0007389;	  C:extracellular space; C:glutamatergic synapse; C:integral component of membrane; C:plasma membrane;	  F:chemorepellent activity; F:growth factor activity; F:signaling receptor binding;	  P:animal organ development; P:chemorepulsion involved in interneuron migration from the subpallium to the cortex; P:intracellular signal transduction; P:mammary gland development; P:mammary placode formation; P:modulation of chemical synaptic transmission; P:negative regulation of neuron migration; P:pattern specification process;
XM_040179224.1	chrVI	16462504	16462504	chrVI	16472723	16474317	+	XM_040179224.1	path1	O93209	Pro-Pol polyprotein	Pr125Pol;	 PF17921;PF00075;PF00665;PF00078;PF18103;PF03539;	 GO:0030430;GO:0042025;GO:0019012;GO:0004190;GO:0003887;GO:0046872;GO:0003723;GO:0003964;GO:0004523;GO:0015074;GO:0006310;GO:0075713;GO:0046718;GO:0044826;GO:0075732;	  C:host cell cytoplasm; C:host cell nucleus; C:virion;	  F:aspartic-type endopeptidase activity; F:DNA-directed DNA polymerase activity; F:metal ion binding; F:RNA binding; F:RNA-directed DNA polymerase activity; F:RNA-DNA hybrid ribonuclease activity;	  P:DNA integration; P:DNA recombination; P:establishment of integrated proviral latency; P:viral entry into host cell; P:viral genome integration into host DNA; P:viral penetration into host nucleus;
XM_040178868.1	chrVI	16553484	16553484	chrVI	16565798	16621541	+	XM_040178868.1	path1	O13156	GDNF family receptor alpha-1	TGF-beta-related neurotrophic factor receptor 1;	 PF02351;	 GO:0031225;GO:0009897;GO:0043235;GO:0038023;GO:0007399;	  C:anchored component of membrane; C:external side of plasma membrane; C:receptor complex;	  F:signaling receptor activity;	  P:nervous system development;
XM_040168904.1	chrVI	16578969	16578969	chrVI	16573653	16622284	+	XM_040168904.1	path1	P56945 B3KWD7 B4DEV4 B4DGB5 B4DIW5 B7Z7X7 E9PCL5 E9PCV2 F5GXA2 F5GXV6 F5H7Z0 F8WA69 Q6QEF7	Breast cancer anti-estrogen resistance protein 1	CRK-associated substrate;Cas scaffolding protein family member 1;p130cas;	 PF12026;PF08824;PF00018;	 GO:0015629;GO:0030424;GO:0005737;GO:0005829;GO:0005925;GO:0030027;GO:0016020;GO:0001726;GO:0019901;GO:0017124;GO:0007015;GO:0090527;GO:0050851;GO:0050853;GO:0007155;GO:0060326;GO:0051301;GO:0016477;GO:0035729;GO:0086100;GO:0007173;GO:0007186;GO:0048012;GO:0008286;GO:0007229;GO:0048011;GO:0048008;GO:0030335;GO:0010595;GO:0042981;GO:0001558;GO:0050852;GO:0007169;GO:0048010;	  C:actin cytoskeleton; C:axon; C:cytoplasm; C:cytosol; C:focal adhesion; C:lamellipodium; C:membrane; C:ruffle;	  F:protein kinase binding; F:SH3 domain binding;	  P:actin filament organization; P:actin filament reorganization; P:antigen receptor-mediated signaling pathway; P:B cell receptor signaling pathway; P:cell adhesion; P:cell chemotaxis; P:cell division; P:cell migration; P:cellular response to hepatocyte growth factor stimulus; P:endothelin receptor signaling pathway; P:epidermal growth factor receptor signaling pathway; P:G protein-coupled receptor signaling pathway; P:hepatocyte growth factor receptor signaling pathway; P:insulin receptor signaling pathway; P:integrin-mediated signaling pathway; P:neurotrophin TRK receptor signaling pathway; P:platelet-derived growth factor receptor signaling pathway; P:positive regulation of cell migration; P:positive regulation of endothelial cell migration; P:regulation of apoptotic process; P:regulation of cell growth; P:T cell receptor signaling pathway; P:transmembrane receptor protein tyrosine kinase signaling pathway; P:vascular endothelial growth factor receptor signaling pathway;
XM_040179009.1	chrVI	16612657	16612657	chrVI	16623993	16746976	-	XM_040179009.1	path1	Q6A051 Q3UHB0 Q68HV2 Q80VI3 Q8BKS4 Q8K0P5	Attractin-like protein 1		 PF00431;PF07974;PF00053;PF00059;PF01437;	 GO:0005604;GO:0016021;GO:0005886;GO:0030246;GO:0009887;GO:0016477;GO:0007186;GO:0034446;GO:0009888;	  C:basement membrane; C:integral component of membrane; C:plasma membrane;	  F:carbohydrate binding;	  P:animal organ morphogenesis; P:cell migration; P:G protein-coupled receptor signaling pathway; P:substrate adhesion-dependent cell spreading; P:tissue development;
XM_040185242.1	chrVIII	11390203	11390203	chrVIII	11317270	11506768	+	XM_040185242.1	path1	Q13332 O75255 O75870 Q15718 Q16341 Q2M3R7	Receptor-type tyrosine-protein phosphatase S	Receptor-type tyrosine-protein phosphatase sigma;	 PF00041;PF07679;PF00102;	 GO:0030424;GO:0005829;GO:0070062;GO:0098978;GO:0030426;GO:0005887;GO:0099061;GO:0099056;GO:0030285;GO:0043204;GO:0005886;GO:0098685;GO:0035374;GO:0043395;GO:0008201;GO:0004721;GO:0004725;GO:0021549;GO:0021987;GO:0022038;GO:0090557;GO:0021766;GO:0050804;GO:0030517;GO:0048681;GO:0048671;GO:0061000;GO:0032687;GO:0032688;GO:0010977;GO:0034164;GO:0035335;GO:0006470;GO:0099151;GO:0021510;GO:0099560;	  C:axon; C:cytosol; C:extracellular exosome; C:glutamatergic synapse; C:growth cone; C:integral component of plasma membrane; C:integral component of postsynaptic density membrane; C:integral component of presynaptic membrane; C:integral component of synaptic vesicle membrane; C:perikaryon; C:plasma membrane; C:Schaffer collateral - CA1 synapse;	  F:chondroitin sulfate binding; F:heparan sulfate proteoglycan binding; F:heparin binding; F:phosphoprotein phosphatase activity; F:protein tyrosine phosphatase activity;	  P:cerebellum development; P:cerebral cortex development; P:corpus callosum development; P:establishment of endothelial intestinal barrier; P:hippocampus development; P:modulation of chemical synaptic transmission; P:negative regulation of axon extension; P:negative regulation of axon regeneration; P:negative regulation of collateral sprouting; P:negative regulation of dendritic spine development; P:negative regulation of interferon-alpha production; P:negative regulation of interferon-beta production; P:negative regulation of neuron projection development; P:negative regulation of toll-like receptor 9 signaling pathway; P:peptidyl-tyrosine dephosphorylation; P:protein dephosphorylation; P:regulation of postsynaptic density assembly; P:spinal cord development; P:synaptic membrane adhesion;
XM_040184947.1	chrVIII	11657660	11657660	chrVIII	11625003	11693173	+	XM_040184947.1	path1	Q7Z7M1 Q86SL4 Q8NH12	Adhesion G-protein coupled receptor D2 {ECO:0000303|PubMed:25713288}	G-protein coupled receptor 144;G-protein coupled receptor PGR24;	 PF00002;PF01825;PF00354;	 GO:0016021;GO:0005887;GO:0004930;GO:0007189;GO:0007166;GO:0007186;	  C:integral component of membrane; C:integral component of plasma membrane;	  F:G protein-coupled receptor activity;	  P:adenylate cyclase-activating G protein-coupled receptor signaling pathway; P:cell surface receptor signaling pathway; P:G protein-coupled receptor signaling pathway;
XM_040184878.1	chrVIII	12565925	12565925	chrVIII	12557225	12564156	+	XM_040184878.1	path1	Q9EPC6 Q9JHU7	Profilin-2	Profilin II;	 PF00235;	 GO:0005737;GO:0005856;GO:0098978;GO:0098794;GO:0098793;GO:0098685;GO:0043195;GO:0003779;GO:0003785;GO:0016887;GO:0005546;GO:0030036;GO:0098885;GO:0030837;GO:0010633;GO:1900028;GO:0032233;GO:0030838;GO:0032781;GO:0033138;GO:0051496;GO:0050821;GO:0030833;GO:2000300;	  C:cytoplasm; C:cytoskeleton; C:glutamatergic synapse; C:postsynapse; C:presynapse; C:Schaffer collateral - CA1 synapse; C:terminal bouton;	  F:actin binding; F:actin monomer binding; F:ATPase activity; F:phosphatidylinositol-4,5-bisphosphate binding;	  P:actin cytoskeleton organization; P:modification of postsynaptic actin cytoskeleton; P:negative regulation of actin filament polymerization; P:negative regulation of epithelial cell migration; P:negative regulation of ruffle assembly; P:positive regulation of actin filament bundle assembly; P:positive regulation of actin filament polymerization; P:positive regulation of ATPase activity; P:positive regulation of peptidyl-serine phosphorylation; P:positive regulation of stress fiber assembly; P:protein stabilization; P:regulation of actin filament polymerization; P:regulation of synaptic vesicle exocytosis;
XM_040184875.1	chrVIII	12565925	12565925	chrVIII	12564024	12571960	-	XM_040184875.1	path1	Q90972 Q533M4	E3 ubiquitin-protein ligase RNF13	C-RZF;RING finger protein 13;RING-type E3 ubiquitin transferase RNF13 {ECO:0000305};	 PF02225;PF13639;	 GO:0005829;GO:0005783;GO:0005789;GO:0016021;GO:0031902;GO:0005765;GO:0005654;GO:0008432;GO:0046872;GO:0061630;GO:0004842;GO:0070304;GO:0051865;GO:0006511;	  C:cytosol; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of membrane; C:late endosome membrane; C:lysosomal membrane; C:nucleoplasm;	  F:JUN kinase binding; F:metal ion binding; F:ubiquitin protein ligase activity; F:ubiquitin-protein transferase activity;	  P:positive regulation of stress-activated protein kinase signaling cascade; P:protein autoubiquitination; P:ubiquitin-dependent protein catabolic process;
XM_040185057.1	chrVIII	12720737	12720737	chrVIII	12726376	12728139	-	XM_040185057.1	path1	Q8AVU4	Transcription factor HES-1-B	Hairy and enhancer of split 1-B;	 PF07527;PF00010;	 GO:0005634;GO:0043425;GO:0003677;GO:0046982;GO:0007275;GO:0048635;GO:0000122;GO:0045892;GO:0007219;	  C:nucleus;	  F:bHLH transcription factor binding; F:DNA binding; F:protein heterodimerization activity;	  P:multicellular organism development; P:negative regulation of muscle organ development; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:Notch signaling pathway;
XM_040184261.1	chrVIII	13129255	13129255	chrVIII	13094564	13207665	-	XM_040184261.1	path1	Q7Z3B1 Q5VT21 Q6UY06 Q8N440 Q8NAQ3	Neuronal growth regulator 1	IgLON family member 4;	 PF07679;	 GO:0031225;GO:0005576;GO:0005886;GO:0098609;GO:0007631;GO:0007626;GO:0010976;	  C:anchored component of membrane; C:extracellular region; C:plasma membrane;	 	  P:cell-cell adhesion; P:feeding behavior; P:locomotory behavior; P:positive regulation of neuron projection development;
XM_040187855.1	chrX	16305683	16305683	chrX	16305113	16314034	-	XM_040187855.1	path1	P62760 D6W515 P28677 P29103 P42323 Q9UM20	Visinin-like protein 1	Hippocalcin-like protein 3;	 PF00036;PF13499;	 GO:0005829;GO:0016020;GO:0005509;GO:0046676;GO:0045921;GO:0035774;	  C:cytosol; C:membrane;	  F:calcium ion binding;	  P:negative regulation of insulin secretion; P:positive regulation of exocytosis; P:positive regulation of insulin secretion involved in cellular response to glucose stimulus;
XM_040192929.1	chrXII	10132797	10132797	chrXII	10121813	10136267	+	XM_040192929.1	path1	O88721	Vasopressin V2 receptor	AVPR V2;Antidiuretic hormone receptor;Renal-type arginine vasopressin receptor;	 PF00001;	 GO:0030139;GO:0005768;GO:0005887;GO:0048471;GO:0005886;GO:0004930;GO:0042277;GO:0005000;GO:0007186;GO:0007249;GO:0008285;GO:0035814;GO:0035811;GO:0045777;GO:0008284;GO:0010628;GO:0003084;GO:0045907;GO:0001992;GO:0034097;GO:0021537;	  C:endocytic vesicle; C:endosome; C:integral component of plasma membrane; C:perinuclear region of cytoplasm; C:plasma membrane;	  F:G protein-coupled receptor activity; F:peptide binding; F:vasopressin receptor activity;	  P:G protein-coupled receptor signaling pathway; P:I-kappaB kinase/NF-kappaB signaling; P:negative regulation of cell population proliferation; P:negative regulation of renal sodium excretion; P:negative regulation of urine volume; P:positive regulation of blood pressure; P:positive regulation of cell population proliferation; P:positive regulation of gene expression; P:positive regulation of systemic arterial blood pressure; P:positive regulation of vasoconstriction; P:regulation of systemic arterial blood pressure by vasopressin; P:response to cytokine; P:telencephalon development;
XM_040192896.1	chrXII	10190117	10190117	chrXII	10171456	10198018	-	XM_040192896.1	path1	O43306 Q9NR75 Q9UDB0	Adenylate cyclase type 6	ATP pyrophosphate-lyase 6;Adenylate cyclase type VI;Adenylyl cyclase 6 {ECO:0000303|PubMed:17916776};Ca(2+)-inhibitable adenylyl cyclase;	 PF16214;PF06327;PF00211;	 GO:0005929;GO:0005887;GO:0031226;GO:0016020;GO:0005886;GO:0032420;GO:0004016;GO:0005524;GO:0046872;GO:0019901;GO:0005080;GO:0007190;GO:0034199;GO:0007189;GO:0007193;GO:0097746;GO:0006171;GO:0071870;GO:1904322;GO:0071377;GO:0071380;GO:1904117;GO:0007212;GO:0007186;GO:0035556;GO:0002862;GO:0010977;GO:0035811;GO:0003091;	  C:cilium; C:integral component of plasma membrane; C:intrinsic component of plasma membrane; C:membrane; C:plasma membrane; C:stereocilium;	  F:adenylate cyclase activity; F:ATP binding; F:metal ion binding; F:protein kinase binding; F:protein kinase C binding;	  P:activation of adenylate cyclase activity; P:activation of protein kinase A activity; P:adenylate cyclase-activating G protein-coupled receptor signaling pathway; P:adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway; P:blood vessel diameter maintenance; P:cAMP biosynthetic process; P:cellular response to catecholamine stimulus; P:cellular response to forskolin; P:cellular response to glucagon stimulus; P:cellular response to prostaglandin E stimulus; P:cellular response to vasopressin; P:dopamine receptor signaling pathway; P:G protein-coupled receptor signaling pathway; P:intracellular signal transduction; P:negative regulation of inflammatory response to antigenic stimulus; P:negative regulation of neuron projection development; P:negative regulation of urine volume; P:renal water homeostasis;
XM_040195741.1	chrXIII	11085100	11085100	chrXIII	10977247	11103396	-	XM_040195741.1	path1	Q7T297	Cotranscriptional regulator FAM172A homolog {ECO:0000250|UniProtKB:Q3TNH5}	Protein FAM172A;	 	 GO:0005737;GO:0005634;GO:0031048;GO:0006397;GO:0000381;GO:0008380;	  C:cytoplasm; C:nucleus;	 	  P:heterochromatin assembly by small RNA; P:mRNA processing; P:regulation of alternative mRNA splicing, via spliceosome; P:RNA splicing;
XM_040196160.1	chrXIII	16653560	16653560	chrXIII	16646042	16671775	-	XM_040196160.1	path1	Q5DUB1	Substance-P receptor	NK-1 receptor;Tachykinin receptor 1;	 PF00001;	 GO:0016021;GO:0005886;GO:0061827;GO:0097225;GO:0016496;GO:0007204;GO:1902093;GO:0070472;GO:0048265;	  C:integral component of membrane; C:plasma membrane; C:sperm head; C:sperm midpiece;	  F:substance P receptor activity;	  P:positive regulation of cytosolic calcium ion concentration; P:positive regulation of flagellated sperm motility; P:regulation of uterine smooth muscle contraction; P:response to pain;
XM_040194697.1	chrXIII	16693494	16693494	chrXIII	16688618	16710676	+	XM_040194697.1	path1	Q6RI88	Electrogenic sodium bicarbonate cotransporter 4	Solute carrier family 4 member 5;	 PF07565;PF00955;	 GO:0016324;GO:0016323;GO:0016021;GO:0005886;GO:0015301;GO:0005452;GO:0008510;GO:0022857;GO:0006820;GO:0015701;GO:0033326;GO:0002064;GO:0050801;GO:0006811;GO:0048311;GO:0010468;GO:0051453;GO:0006885;GO:0003073;GO:0003014;GO:0060041;GO:0055085;	  C:apical plasma membrane; C:basolateral plasma membrane; C:integral component of membrane; C:plasma membrane;	  F:anion:anion antiporter activity; F:inorganic anion exchanger activity; F:sodium:bicarbonate symporter activity; F:transmembrane transporter activity;	  P:anion transport; P:bicarbonate transport; P:cerebrospinal fluid secretion; P:epithelial cell development; P:ion homeostasis; P:ion transport; P:mitochondrion distribution; P:regulation of gene expression; P:regulation of intracellular pH; P:regulation of pH; P:regulation of systemic arterial blood pressure; P:renal system process; P:retina development in camera-type eye; P:transmembrane transport;
XM_040194695.1	chrXIII	16891929	16891929	chrXIII	16832388	16881995	-	XM_040194695.1	path1	O14976 Q5U4P5 Q9BVY6	Cyclin-G-associated kinase		 PF00069;PF10409;	 GO:0005737;GO:0005829;GO:0005925;GO:0005794;GO:0043231;GO:0016020;GO:0048471;GO:0098793;GO:0031982;GO:0005524;GO:0051087;GO:0030276;GO:0030332;GO:0106310;GO:0004674;GO:0106311;GO:0007049;GO:0051085;GO:0072318;GO:1905224;GO:0072583;GO:0007029;GO:0007030;GO:0090160;GO:0061024;GO:0010977;GO:0034067;GO:0072659;GO:0006898;GO:0016191;	  C:cytoplasm; C:cytosol; C:focal adhesion; C:Golgi apparatus; C:intracellular membrane-bounded organelle; C:membrane; C:perinuclear region of cytoplasm; C:presynapse; C:vesicle;	  F:ATP binding; F:chaperone binding; F:clathrin binding; F:cyclin binding; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;	  P:cell cycle; P:chaperone cofactor-dependent protein refolding; P:clathrin coat disassembly; P:clathrin-coated pit assembly; P:clathrin-dependent endocytosis; P:endoplasmic reticulum organization; P:Golgi organization; P:Golgi to lysosome transport; P:membrane organization; P:negative regulation of neuron projection development; P:protein localization to Golgi apparatus; P:protein localization to plasma membrane; P:receptor-mediated endocytosis; P:synaptic vesicle uncoating;
XM_040195986.1	chrXIII	16891928	16891928	chrXIII	16884885	16910275	+	XM_040195986.1	path1	A3QK15 Q7ZU87	Acetoacetyl-CoA synthetase		 PF16177;PF00501;	 GO:0005829;GO:0030729;GO:0005524;GO:0006631;GO:0032024;	  C:cytosol;	  F:acetoacetate-CoA ligase activity; F:ATP binding;	  P:fatty acid metabolic process; P:positive regulation of insulin secretion;
XM_040195985.1	chrXIII	16947343	16947343	chrXIII	16932602	17079402	+	XM_040195985.1	path1	Q8CEF9 Q8BS69	Transmembrane protein 132C		 PF16070;PF15706;PF15705;	 GO:0016021;GO:0010923;	  C:integral component of membrane;	 	  P:negative regulation of phosphatase activity;
XR_005714011.1	chrXIII	17457812	17457812	chrXIII	17440620	17446255	+	XR_005714011.1	path1	Q5VXU9 A2A2V3 Q2M1H8 Q96M73	Protein shortage in chiasmata 1 ortholog {ECO:0000305}	Protein ZIP2 homolog {ECO:0000250|UniProtKB:A2ALV5};	 PF17825;	 GO:0005694;GO:0000794;GO:0016887;GO:0003697;GO:0007131;GO:0000712;	  C:chromosome; C:condensed nuclear chromosome;	  F:ATPase activity; F:single-stranded DNA binding;	  P:reciprocal meiotic recombination; P:resolution of meiotic recombination intermediates;
XM_040196671.1	chrXIII	17461856	17461856	chrXIII	17453233	17461950	-	XM_040196671.1	path1	Q7RTR2 Q5EY36 Q8NF48 Q8NI01 Q8NI02 Q8TEL3	NLR family CARD domain-containing protein 3	CARD15-like protein;Caterpiller protein 16.2 {ECO:0000303|PubMed:15705585};NACHT, LRR and CARD domains-containing protein 3;Nucleotide-binding oligomerization domain protein 3;	 PF13516;PF05729;PF17776;PF17779;	 GO:0034451;GO:0005737;GO:0005829;GO:0043231;GO:0048471;GO:0005524;GO:0036312;GO:0007249;GO:0035556;GO:1900016;GO:0050680;GO:0048147;GO:0043124;GO:0050728;GO:0045824;GO:0032687;GO:0032688;GO:0032715;GO:0032088;GO:1901223;GO:1900226;GO:0014067;GO:0032720;GO:0042110;	  C:centriolar satellite; C:cytoplasm; C:cytosol; C:intracellular membrane-bounded organelle; C:perinuclear region of cytoplasm;	  F:ATP binding; F:phosphatidylinositol 3-kinase regulatory subunit binding;	  P:I-kappaB kinase/NF-kappaB signaling; P:intracellular signal transduction; P:negative regulation of cytokine production involved in inflammatory response; P:negative regulation of epithelial cell proliferation; P:negative regulation of fibroblast proliferation; P:negative regulation of I-kappaB kinase/NF-kappaB signaling; P:negative regulation of inflammatory response; P:negative regulation of innate immune response; P:negative regulation of interferon-alpha production; P:negative regulation of interferon-beta production; P:negative regulation of interleukin-6 production; P:negative regulation of NF-kappaB transcription factor activity; P:negative regulation of NIK/NF-kappaB signaling; P:negative regulation of NLRP3 inflammasome complex assembly; P:negative regulation of phosphatidylinositol 3-kinase signaling; P:negative regulation of tumor necrosis factor production; P:T cell activation;
XM_040196842.1	chrXIV	3728199	3728199	chrXIV	3720439	3726315	-	XM_040196842.1	path1	Q5R4Q8	Protein prune homolog 2	BNIP2 motif-containing molecule at the C-terminal region 1;	 PF12496;PF13716;	 GO:0005737;GO:0006915;	  C:cytoplasm;	 	  P:apoptotic process;
XM_040196840.1	chrXIV	3727929	3727929	chrXIV	3727451	3733041	-	XM_040196840.1	path1	O95837 B1ALW3	Guanine nucleotide-binding protein subunit alpha-14		 PF00503;	 GO:0070062;GO:0005834;GO:0005886;GO:0001664;GO:0031683;GO:0005525;GO:0003924;GO:0046872;GO:0031826;GO:0001508;GO:0007188;GO:0007186;GO:0060158;GO:0030168;GO:0007165;	  C:extracellular exosome; C:heterotrimeric G-protein complex; C:plasma membrane;	  F:G protein-coupled receptor binding; F:G-protein beta/gamma-subunit complex binding; F:GTP binding; F:GTPase activity; F:metal ion binding; F:type 2A serotonin receptor binding;	  P:action potential; P:adenylate cyclase-modulating G protein-coupled receptor signaling pathway; P:G protein-coupled receptor signaling pathway; P:phospholipase C-activating dopamine receptor signaling pathway; P:platelet activation; P:signal transduction;
XM_040196839.1	chrXIV	3731588	3731588	chrXIV	3733794	3742775	-	XM_040196839.1	path1	P50148 O15108 Q13462 Q6NT27 Q92471 Q9BZB9	Guanine nucleotide-binding protein G(q) subunit alpha	Guanine nucleotide-binding protein alpha-q;	 PF00503;	 GO:0005737;GO:0070062;GO:0005794;GO:0005834;GO:0005765;GO:0031965;GO:0001750;GO:0005886;GO:0045202;GO:0001664;GO:0031683;GO:0005525;GO:0005096;GO:0003924;GO:0046872;GO:0031826;GO:0001508;GO:0007202;GO:0007189;GO:0007188;GO:0007596;GO:0009649;GO:0007213;GO:0007186;GO:0007215;GO:0006469;GO:0007603;GO:0030168;GO:0050821;GO:0060828;	  C:cytoplasm; C:extracellular exosome; C:Golgi apparatus; C:heterotrimeric G-protein complex; C:lysosomal membrane; C:nuclear membrane; C:photoreceptor outer segment; C:plasma membrane; C:synapse;	  F:G protein-coupled receptor binding; F:G-protein beta/gamma-subunit complex binding; F:GTP binding; F:GTPase activator activity; F:GTPase activity; F:metal ion binding; F:type 2A serotonin receptor binding;	  P:action potential; P:activation of phospholipase C activity; P:adenylate cyclase-activating G protein-coupled receptor signaling pathway; P:adenylate cyclase-modulating G protein-coupled receptor signaling pathway; P:blood coagulation; P:entrainment of circadian clock; P:G protein-coupled acetylcholine receptor signaling pathway; P:G protein-coupled receptor signaling pathway; P:glutamate receptor signaling pathway; P:negative regulation of protein kinase activity; P:phototransduction, visible light; P:platelet activation; P:protein stabilization; P:regulation of canonical Wnt signaling pathway;
XM_040197929.1	chrXIV	3781839	3781839	chrXIV	3777086	3805038	-	XM_040197929.1	path1	P56199 B2RNU0	Integrin alpha-1	CD49 antigen-like family member A;Laminin and collagen receptor;VLA-1;	 PF01839;PF08441;PF00092;	 GO:0001669;GO:0045178;GO:0009986;GO:0009897;GO:0070062;GO:0005925;GO:0034665;GO:0008305;GO:0016020;GO:0045121;GO:0043005;GO:0043204;GO:0005886;GO:0005518;GO:0098639;GO:0046872;GO:0019903;GO:0005102;GO:0000187;GO:0007160;GO:0045123;GO:0030198;GO:0007229;GO:0006936;GO:0008285;GO:0042059;GO:0048812;GO:0030593;GO:0043525;GO:0032516;GO:0042311;	  C:acrosomal vesicle; C:basal part of cell; C:cell surface; C:external side of plasma membrane; C:extracellular exosome; C:focal adhesion; C:integrin alpha1-beta1 complex; C:integrin complex; C:membrane; C:membrane raft; C:neuron projection; C:perikaryon; C:plasma membrane;	  F:collagen binding; F:collagen binding involved in cell-matrix adhesion; F:metal ion binding; F:protein phosphatase binding; F:signaling receptor binding;	  P:activation of MAPK activity; P:cell-matrix adhesion; P:cellular extravasation; P:extracellular matrix organization; P:integrin-mediated signaling pathway; P:muscle contraction; P:negative regulation of cell population proliferation; P:negative regulation of epidermal growth factor receptor signaling pathway; P:neuron projection morphogenesis; P:neutrophil chemotaxis; P:positive regulation of neuron apoptotic process; P:positive regulation of phosphoprotein phosphatase activity; P:vasodilation;
XM_040197990.1	chrXIV	3837660	3837660	chrXIV	3830238	3838281	-	XM_040197990.1	path1	Q6PGC1 Q8BQJ4 Q8BT01 Q8C9B7 Q8C9H9	ATP-dependent RNA helicase DHX29 {ECO:0000255|HAMAP-Rule:MF_03068}	DEAH box protein 29 {ECO:0000255|HAMAP-Rule:MF_03068};	 PF00270;PF04408;PF00271;PF07717;	 GO:0022627;GO:0016282;GO:0005739;GO:0005524;GO:0017111;GO:0043024;GO:0003723;GO:0003724;GO:0008494;GO:0003743;GO:0001731;GO:0045948;GO:0042255;	  C:cytosolic small ribosomal subunit; C:eukaryotic 43S preinitiation complex; C:mitochondrion;	  F:ATP binding; F:nucleoside-triphosphatase activity; F:ribosomal small subunit binding; F:RNA binding; F:RNA helicase activity; F:translation activator activity; F:translation initiation factor activity;	  P:formation of translation preinitiation complex; P:positive regulation of translational initiation; P:ribosome assembly;
XM_040198246.1	chrXIV	3837660	3837660	chrXIV	3838354	3839109	+	XM_040198246.1	path1	Q9CZU3	Exosome RNA helicase MTR4 {ECO:0000305}	ATP-dependent helicase SKIV2L2;Superkiller viralicidic activity 2-like 2;TRAMP-like complex helicase;	 PF00270;PF08148;PF00271;PF13234;	 GO:0071013;GO:0000176;GO:0016607;GO:0005730;GO:0005654;GO:0005634;GO:0031499;GO:0005524;GO:0003723;GO:0003724;GO:0006974;GO:0000460;GO:0006397;GO:0006401;GO:0008380;GO:0006364;	  C:catalytic step 2 spliceosome; C:nuclear exosome (RNase complex); C:nuclear speck; C:nucleolus; C:nucleoplasm; C:nucleus; C:TRAMP complex;	  F:ATP binding; F:RNA binding; F:RNA helicase activity;	  P:cellular response to DNA damage stimulus; P:maturation of 5.8S rRNA; P:mRNA processing; P:RNA catabolic process; P:RNA splicing; P:rRNA processing;
XM_040197992.1	chrXIV	3837660	3837660	chrXIV	3839631	3850969	+	XM_040197992.1	path1	P42285 Q2M386 Q6MZZ8 Q6P170 Q8N5R0 Q8TAG2	Exosome RNA helicase MTR4 {ECO:0000305}	ATP-dependent RNA helicase DOB1 {ECO:0000303|PubMed:16782053};ATP-dependent RNA helicase SKIV2L2;Superkiller viralicidic activity 2-like 2;TRAMP-like complex helicase;	 PF00270;PF08148;PF00271;PF13234;	 GO:0071013;GO:0016607;GO:0005730;GO:0005654;GO:0005634;GO:0031499;GO:0005524;GO:0003723;GO:0003724;GO:0006974;GO:0000460;GO:0000398;GO:0006401;GO:0006364;GO:0016076;	  C:catalytic step 2 spliceosome; C:nuclear speck; C:nucleolus; C:nucleoplasm; C:nucleus; C:TRAMP complex;	  F:ATP binding; F:RNA binding; F:RNA helicase activity;	  P:cellular response to DNA damage stimulus; P:maturation of 5.8S rRNA; P:mRNA splicing, via spliceosome; P:RNA catabolic process; P:rRNA processing; P:snRNA catabolic process;
XM_040197052.1	chrXIV	4036199	4036199	chrXIV	4029724	4051184	-	XM_040197052.1	path1	Q12923 B2RTR0 Q15159 Q15263 Q15264 Q15265 Q15674 Q16826 Q8IWH7 Q9NYN9 Q9UDA8	Tyrosine-protein phosphatase non-receptor type 13	Fas-associated protein-tyrosine phosphatase 1;PTP-BAS;Protein-tyrosine phosphatase 1E;Protein-tyrosine phosphatase PTPL1;	 PF09380;PF00373;PF09379;PF00595;PF00102;	 GO:0044297;GO:0005737;GO:0005856;GO:0005829;GO:0070062;GO:0001650;GO:0030027;GO:0043005;GO:0005654;GO:0005634;GO:0005886;GO:0036312;GO:0004725;GO:0071345;GO:0001933;GO:0035335;GO:0006661;GO:0006470;GO:0014066;	  C:cell body; C:cytoplasm; C:cytoskeleton; C:cytosol; C:extracellular exosome; C:fibrillar center; C:lamellipodium; C:neuron projection; C:nucleoplasm; C:nucleus; C:plasma membrane;	  F:phosphatidylinositol 3-kinase regulatory subunit binding; F:protein tyrosine phosphatase activity;	  P:cellular response to cytokine stimulus; P:negative regulation of protein phosphorylation; P:peptidyl-tyrosine dephosphorylation; P:phosphatidylinositol biosynthetic process; P:protein dephosphorylation; P:regulation of phosphatidylinositol 3-kinase signaling;
XM_040196889.1	chrXIV	4107366	4107366	chrXIV	4091693	4102186	-	XM_040196889.1	path1	Q8N264 Q4KMG1 Q6ZNV3 Q86TI5 Q86WE4 Q9H0T6	Rho GTPase-activating protein 24	Filamin-A-associated RhoGAP;RAC1- and CDC42-specific GTPase-activating protein of 72 kDa;Rho-type GTPase-activating protein 24;RhoGAP of 73 kDa;Sarcoma antigen NY-SAR-88;p73RhoGAP;	 PF00169;PF00620;	 GO:0005912;GO:0042995;GO:0005856;GO:0005829;GO:0005925;GO:0005096;GO:0090630;GO:0001525;GO:0030154;GO:0035021;GO:1900028;GO:0051056;GO:0007165;GO:0035313;	  C:adherens junction; C:cell projection; C:cytoskeleton; C:cytosol; C:focal adhesion;	  F:GTPase activator activity;	  P:activation of GTPase activity; P:angiogenesis; P:cell differentiation; P:negative regulation of Rac protein signal transduction; P:negative regulation of ruffle assembly; P:regulation of small GTPase mediated signal transduction; P:signal transduction; P:wound healing, spreading of epidermal cells;
XM_040197137.1	chrXIV	4136827	4136827	chrXIV	4140705	4142507	-	XM_040197137.1	path1	P97682	Endothelial cell-specific molecule 1	PG25;	 PF00219;	 GO:0005576;GO:0005171;GO:0005520;GO:0005178;GO:0001525;GO:0008284;GO:1902204;GO:0002040;	  C:extracellular region;	  F:hepatocyte growth factor receptor binding; F:insulin-like growth factor binding; F:integrin binding;	  P:angiogenesis; P:positive regulation of cell population proliferation; P:positive regulation of hepatocyte growth factor receptor signaling pathway; P:sprouting angiogenesis;
XM_040197130.1	chrXIV	4136827	4136827	chrXIV	4142836	4177170	+	XM_040197130.1	path1	Q15751 Q8IW65	Probable E3 ubiquitin-protein ligase HERC1	HECT domain and RCC1-like domain-containing protein 1;HECT-type E3 ubiquitin transferase HERC1;p532;p619;	 PF00632;PF00415;PF00622;PF00400;	 GO:0005737;GO:0005829;GO:0005794;GO:0016020;GO:0005085;GO:0004842;GO:0021702;GO:0010507;GO:0050885;GO:0031175;	  C:cytoplasm; C:cytosol; C:Golgi apparatus; C:membrane;	  F:guanyl-nucleotide exchange factor activity; F:ubiquitin-protein transferase activity;	  P:cerebellar Purkinje cell differentiation; P:negative regulation of autophagy; P:neuromuscular process controlling balance; P:neuron projection development;
XM_040197322.1	chrXIV	6762760	6762760	chrXIV	6737533	6767480	-	XM_040197322.1	path1	Q0VA16	WD repeat-containing protein 70		 PF00400;	 GO:0005634;GO:0035861;GO:1903775;GO:2001173;	  C:nucleus; C:site of double-strand break;	 	  P:regulation of DNA double-strand break processing; P:regulation of histone H2B conserved C-terminal lysine ubiquitination;
XM_040197316.1	chrXIV	6762760	6762760	chrXIV	6767773	6784674	-	XM_040197316.1	path1	Q8CE72 E9QL36 Q3UXY6 Q6PEE0	Ciliogenesis and planar polarity effector 1 {ECO:0000305}	Protein C5orf42 homolog;Protein JBTS17 {ECO:0000303|PubMed:25877302, ECO:0000303|PubMed:27158779};	 PF15392;	 GO:0035869;GO:0016021;GO:0003279;GO:0021549;GO:0060271;GO:0060976;GO:0042733;GO:0001736;GO:0007507;GO:0001822;GO:1904491;GO:0060021;GO:0003281;	  C:ciliary transition zone; C:integral component of membrane;	 	  P:cardiac septum development; P:cerebellum development; P:cilium assembly; P:coronary vasculature development; P:embryonic digit morphogenesis; P:establishment of planar polarity; P:heart development; P:kidney development; P:protein localization to ciliary transition zone; P:roof of mouth development; P:ventricular septum development;
XM_040198583.1	chrXIV	6942125	6942125	chrXIV	6923900	6932914	-	XM_040198583.1	path1	Q8N1T3 F5H3C6	Unconventional myosin-Ih	Myosin-1H;	 PF00063;PF06017;	 GO:0015629;GO:0005737;GO:0005902;GO:0016459;GO:0005886;GO:0031982;GO:0051015;GO:0030898;GO:0005524;GO:0000146;GO:0007015;GO:0030050;	  C:actin cytoskeleton; C:cytoplasm; C:microvillus; C:myosin complex; C:plasma membrane; C:vesicle;	  F:actin filament binding; F:actin-dependent ATPase activity; F:ATP binding; F:microfilament motor activity;	  P:actin filament organization; P:vesicle transport along actin filament;
XM_040197706.1	chrXIV	6942125	6942125	chrXIV	6943434	6957374	+	XM_040197706.1	path1	Q76I79 Q3TDG3 Q69ZM4 Q811E5	Protein phosphatase Slingshot homolog 1	SSH-like protein 1;	 PF08766;	 GO:0031252;GO:0042995;GO:0032154;GO:0005737;GO:0005856;GO:0005829;GO:0030426;GO:0030496;GO:0005886;GO:0045202;GO:0003779;GO:0004721;GO:0106306;GO:0106307;GO:0004725;GO:0008138;GO:0030036;GO:0000902;GO:0071318;GO:0098976;GO:0030837;GO:1904719;GO:2000463;GO:1901216;GO:0031915;GO:1904754;GO:0006470;GO:0032268;	  C:cell leading edge; C:cell projection; C:cleavage furrow; C:cytoplasm; C:cytoskeleton; C:cytosol; C:growth cone; C:midbody; C:plasma membrane; C:synapse;	  F:actin binding; F:phosphoprotein phosphatase activity; F:protein serine phosphatase activity; F:protein threonine phosphatase activity; F:protein tyrosine phosphatase activity; F:protein tyrosine/serine/threonine phosphatase activity;	  P:actin cytoskeleton organization; P:cell morphogenesis; P:cellular response to ATP; P:excitatory chemical synaptic transmission; P:negative regulation of actin filament polymerization; P:positive regulation of AMPA glutamate receptor clustering; P:positive regulation of excitatory postsynaptic potential; P:positive regulation of neuron death; P:positive regulation of synaptic plasticity; P:positive regulation of vascular associated smooth muscle cell migration; P:protein dephosphorylation; P:regulation of cellular protein metabolic process;
XM_040197701.1	chrXIV	6953837	6953837	chrXIV	6960009	6971398	+	XM_040197701.1	path1	B0R0D7 Q7ZW06	Coronin-1C-A {ECO:0000305}		 PF08953;PF00400;	 GO:0015629;GO:0005938;GO:0010008;GO:0030027;GO:0032587;GO:0051015;GO:0007015;GO:0016477;GO:0016197;GO:0140285;GO:0097750;GO:0090148;GO:0001755;	  C:actin cytoskeleton; C:cell cortex; C:endosome membrane; C:lamellipodium; C:ruffle membrane;	  F:actin filament binding;	  P:actin filament organization; P:cell migration; P:endosomal transport; P:endosome fission; P:endosome membrane tubulation; P:membrane fission; P:neural crest cell migration;
XM_040199545.1	chrXV	9097660	9097660	chrXV	9089197	9092349	+	XM_040199545.1	path1	P62699 D6W568 Q65Z97 Q8R174 Q9D6M1 Q9UMX7 Q9Y3C9	Protein yippee-like 5		 PF03226;	 GO:0005576;GO:1904813;GO:0005815;GO:0030496;GO:0097431;GO:0005634;GO:1904724;GO:0000151;GO:0046872;GO:0008283;GO:0043312;	  C:extracellular region; C:ficolin-1-rich granule lumen; C:microtubule organizing center; C:midbody; C:mitotic spindle pole; C:nucleus; C:tertiary granule lumen; C:ubiquitin ligase complex;	  F:metal ion binding;	  P:cell population proliferation; P:neutrophil degranulation;
XM_040199544.1	chrXV	9097660	9097660	chrXV	9094257	9100309	-	XM_040199544.1	path1	Q5F3X0	Lysocardiolipin acyltransferase 1	1-acylglycerol-3-phosphate O-acyltransferase 8 {ECO:0000250|UniProtKB:Q6UWP7};Acyl-CoA:lysocardiolipin acyltransferase 1 {ECO:0000250|UniProtKB:Q3UN02};	 PF16076;PF01553;	 GO:0012505;GO:0005783;GO:0005789;GO:0016021;GO:0003841;GO:0016746;GO:0016024;GO:0007275;GO:0036149;	  C:endomembrane system; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of membrane;	  F:1-acylglycerol-3-phosphate O-acyltransferase activity; F:transferase activity, transferring acyl groups;	  P:CDP-diacylglycerol biosynthetic process; P:multicellular organism development; P:phosphatidylinositol acyl-chain remodeling;
XM_040199509.1	chrXV	9218026	9218026	chrXV	9206024	9225180	+	XM_040199509.1	path1	O46606	Phospholipase DDHD1 {ECO:0000305}	DDHD domain-containing protein 1;Phosphatidic acid-preferring phospholipase A1;	 PF02862;	 GO:0005737;GO:0046872;GO:0004620;GO:0016042;	  C:cytoplasm;	  F:metal ion binding; F:phospholipase activity;	  P:lipid catabolic process;
XM_040199638.1	chrXV	9218026	9218026	chrXV	9227402	9260913	+	XM_040199638.1	path1	F1Q8X5 Q58EF4	Fermitin family homolog 2	Kindlin-2;	 PF00373;PF18124;PF00169;	 GO:0005938;GO:0009986;GO:0030055;GO:0005856;GO:0031234;GO:0005925;GO:0031674;GO:0014704;GO:0031258;GO:0005634;GO:0005178;GO:0008289;GO:0001525;GO:0055008;GO:0016477;GO:0007160;GO:0007010;GO:0007229;GO:0008360;GO:0016055;	  C:cell cortex; C:cell surface; C:cell-substrate junction; C:cytoskeleton; C:extrinsic component of cytoplasmic side of plasma membrane; C:focal adhesion; C:I band; C:intercalated disc; C:lamellipodium membrane; C:nucleus;	  F:integrin binding; F:lipid binding;	  P:angiogenesis; P:cardiac muscle tissue morphogenesis; P:cell migration; P:cell-matrix adhesion; P:cytoskeleton organization; P:integrin-mediated signaling pathway; P:regulation of cell shape; P:Wnt signaling pathway;
XM_040199096.1	chrXV	12249627	12249627	chrXV	12236568	12272182	+	XM_040199096.1	path1	Q86VP3 A2VDJ9 G8JLK3 O60342 Q6P191 Q96FL7	Phosphofurin acidic cluster sorting protein 2	PACS1-like protein;	 PF10254;	 GO:0005783;GO:0005739;GO:0044325;GO:0006915;GO:0000045;GO:0032469;GO:1990456;GO:0034497;GO:0072659;GO:0016032;	  C:endoplasmic reticulum; C:mitochondrion;	  F:ion channel binding;	  P:apoptotic process; P:autophagosome assembly; P:endoplasmic reticulum calcium ion homeostasis; P:mitochondrion-endoplasmic reticulum membrane tethering; P:protein localization to phagophore assembly site; P:protein localization to plasma membrane; P:viral process;
XM_040199097.1	chrXV	12275052	12275052	chrXV	12275104	12288038	+	XM_040199097.1	path1	Q80T85 Q80VT3 Q80ZW6 Q8BIP8 Q8BVK5 Q8K0Q6	DDB1- and CUL4-associated factor 5	WD repeat-containing protein 22;	 PF00400;	 GO:0080008;GO:0005737;GO:0005739;GO:0016567;	  C:Cul4-RING E3 ubiquitin ligase complex; C:cytoplasm; C:mitochondrion;	 	  P:protein ubiquitination;
XM_040202364.1	chrXVI	13384292	13384292	chrXVI	13393873	13399018	-	XM_040202364.1	path1	Q5RAL4	Syntaxin-19		 PF00804;	 GO:0005737;GO:0016021;GO:0005886;GO:0005484;GO:0006886;GO:0016192;	  C:cytoplasm; C:integral component of membrane; C:plasma membrane;	  F:SNAP receptor activity;	  P:intracellular protein transport; P:vesicle-mediated transport;
XM_040202470.1	chrXVI	14902915	14902915	chrXVI	14873837	14889520	+	XM_040202470.1	path1	P22727 Q80ZM9	Protein Wnt-6		 PF00110;	 GO:0009986;GO:0005788;GO:0031012;GO:0005615;GO:0005125;GO:0005109;GO:0005102;GO:0009887;GO:0009798;GO:0001658;GO:0060070;GO:0045165;GO:0007267;GO:0060684;GO:0072080;GO:0072079;GO:0030182;GO:0042475;GO:0010628;GO:0070172;GO:0045893;GO:0007165;GO:0016055;	  C:cell surface; C:endoplasmic reticulum lumen; C:extracellular matrix; C:extracellular space;	  F:cytokine activity; F:frizzled binding; F:signaling receptor binding;	  P:animal organ morphogenesis; P:axis specification; P:branching involved in ureteric bud morphogenesis; P:canonical Wnt signaling pathway; P:cell fate commitment; P:cell-cell signaling; P:epithelial-mesenchymal cell signaling; P:nephron tubule development; P:nephron tubule formation; P:neuron differentiation; P:odontogenesis of dentin-containing tooth; P:positive regulation of gene expression; P:positive regulation of tooth mineralization; P:positive regulation of transcription, DNA-templated; P:signal transduction; P:Wnt signaling pathway;
XM_040202471.1	chrXVI	14902915	14902915	chrXVI	14898792	14915892	+	XM_040202471.1	path1	P43446	Protein Wnt-10a		 PF00110;	 GO:0005615;GO:0005125;GO:0005109;GO:0060070;GO:0045165;GO:0030182;GO:0042476;	  C:extracellular space;	  F:cytokine activity; F:frizzled binding;	  P:canonical Wnt signaling pathway; P:cell fate commitment; P:neuron differentiation; P:odontogenesis;
XM_040202159.1	chrXVI	14975319	14975319	chrXVI	14960273	14965685	-	XM_040202159.1	path1	A3FEM2	Protein FEV	Protein Pet-1;	 PF00178;	 GO:0005634;GO:0000981;GO:0000976;GO:0030154;GO:0060218;GO:0007399;GO:0006357;GO:0006355;	  C:nucleus;	  F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:transcription regulatory region sequence-specific DNA binding;	  P:cell differentiation; P:hematopoietic stem cell differentiation; P:nervous system development; P:regulation of transcription by RNA polymerase II; P:regulation of transcription, DNA-templated;
XM_040202155.1	chrXVI	14975319	14975319	chrXVI	14966764	14969432	-	XM_040202155.1	path1	P55164	Beta-crystallin A2	Beta-A2 crystallin;	 PF00030;	 GO:0005212;GO:0002088;GO:0007601;	 	  F:structural constituent of eye lens;	  P:lens development in camera-type eye; P:visual perception;
XM_040202033.1	chrXVI	14975319	14975319	chrXVI	14976882	14981271	-	XM_040202033.1	path1	P11172 B5LY68 B5LY72 O00758 O00759 O00760 Q16862 Q9H3Q2 Q9UG49	Uridine 5'-monophosphate synthase		 PF00215;PF00156;	 GO:0005737;GO:0005829;GO:0005634;GO:0042802;GO:0004588;GO:0004590;GO:0006207;GO:0044205;GO:0035690;GO:0007565;GO:0007595;GO:0019856;GO:0046134;GO:0006222;	  C:cytoplasm; C:cytosol; C:nucleus;	  F:identical protein binding; F:orotate phosphoribosyltransferase activity; F:orotidine-5'-phosphate decarboxylase activity;	  P:'de novo' pyrimidine nucleobase biosynthetic process; P:'de novo' UMP biosynthetic process; P:cellular response to drug; P:female pregnancy; P:lactation; P:pyrimidine nucleobase biosynthetic process; P:pyrimidine nucleoside biosynthetic process; P:UMP biosynthetic process;
XM_040201713.1	chrXVI	14975319	14975319	chrXVI	14982859	15006759	-	XM_040201713.1	path1	P07589	Fibronectin {ECO:0000250|UniProtKB:P02751}		 PF00039;PF00040;PF00041;	 GO:0062023;GO:0005576;GO:0005615;GO:0097718;GO:0008201;GO:0005178;GO:0043394;GO:0005102;GO:0006953;GO:0001525;GO:0072378;GO:0007160;GO:0007044;GO:0007507;GO:0007399;GO:0070527;GO:0008360;	  C:collagen-containing extracellular matrix; C:extracellular region; C:extracellular space;	  F:disordered domain specific binding; F:heparin binding; F:integrin binding; F:proteoglycan binding; F:signaling receptor binding;	  P:acute-phase response; P:angiogenesis; P:blood coagulation, fibrin clot formation; P:cell-matrix adhesion; P:cell-substrate junction assembly; P:heart development; P:nervous system development; P:platelet aggregation; P:regulation of cell shape;
XM_040202218.1	chrXVI	15073788	15073788	chrXVI	15065695	15199589	+	XM_040202218.1	path1	Q9CSB4 Q5SV53	Partitioning defective 3 homolog B	Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 19 protein homolog;PAR3-beta;Partitioning defective 3-like protein;	 PF12053;PF00595;	 GO:0005912;GO:0043296;GO:0016324;GO:0005923;GO:0005938;GO:0030054;GO:0012505;GO:0032991;GO:0035091;GO:0007155;GO:0007049;GO:0051301;GO:0030010;GO:0051660;GO:0045197;GO:0000226;GO:0008104;	  C:adherens junction; C:apical junction complex; C:apical plasma membrane; C:bicellular tight junction; C:cell cortex; C:cell junction; C:endomembrane system; C:protein-containing complex;	  F:phosphatidylinositol binding;	  P:cell adhesion; P:cell cycle; P:cell division; P:establishment of cell polarity; P:establishment of centrosome localization; P:establishment or maintenance of epithelial cell apical/basal polarity; P:microtubule cytoskeleton organization; P:protein localization;
XM_040204326.1	chrXVII	812046	812046	chrXVII	773763	855195	+	XM_040204326.1	path1	P35400	Metabotropic glutamate receptor 7		 PF00003;PF01094;PF07562;	 GO:0032279;GO:0030424;GO:0043679;GO:0005938;GO:0009986;GO:0030425;GO:0043198;GO:0098982;GO:0098978;GO:0005794;GO:0016021;GO:0005887;GO:0099059;GO:0099056;GO:0016020;GO:0043025;GO:0045211;GO:0048786;GO:0042734;GO:0032991;GO:0043235;GO:0005791;GO:0045202;GO:0043195;GO:0001640;GO:0005246;GO:0048306;GO:0005516;GO:0016595;GO:0008066;GO:0001642;GO:0042802;GO:0030165;GO:0070905;GO:0005245;GO:0007196;GO:0030534;GO:0008306;GO:0001662;GO:0007268;GO:0001661;GO:0007216;GO:0007611;GO:0007613;GO:0033555;GO:0014050;GO:0043524;GO:0050877;GO:0051966;GO:2000300;GO:0007605;GO:0007614;GO:0019226;	  C:asymmetric synapse; C:axon; C:axon terminus; C:cell cortex; C:cell surface; C:dendrite; C:dendritic shaft; C:GABA-ergic synapse; C:glutamatergic synapse; C:Golgi apparatus; C:integral component of membrane; C:integral component of plasma membrane; C:integral component of presynaptic active zone membrane; C:integral component of presynaptic membrane; C:membrane; C:neuronal cell body; C:postsynaptic membrane; C:presynaptic active zone; C:presynaptic membrane; C:protein-containing complex; C:receptor complex; C:rough endoplasmic reticulum; C:synapse; C:terminal bouton;	  F:adenylate cyclase inhibiting G protein-coupled glutamate receptor activity; F:calcium channel regulator activity; F:calcium-dependent protein binding; F:calmodulin binding; F:glutamate binding; F:glutamate receptor activity; F:group III metabotropic glutamate receptor activity; F:identical protein binding; F:PDZ domain binding; F:serine binding; F:voltage-gated calcium channel activity;	  P:adenylate cyclase-inhibiting G protein-coupled glutamate receptor signaling pathway; P:adult behavior; P:associative learning; P:behavioral fear response; P:chemical synaptic transmission; P:conditioned taste aversion; P:G protein-coupled glutamate receptor signaling pathway; P:learning or memory; P:memory; P:multicellular organismal response to stress; P:negative regulation of glutamate secretion; P:negative regulation of neuron apoptotic process; P:nervous system process; P:regulation of synaptic transmission, glutamatergic; P:regulation of synaptic vesicle exocytosis; P:sensory perception of sound; P:short-term memory; P:transmission of nerve impulse;
XM_040203130.1	chrXVII	1044468	1044468	chrXVII	1041419	1045316	+	XM_040203130.1	path1	Q8NCE0 B7Z6K1 C9IZI7 G5E9Q3 Q8WTW7 Q9BPU7	tRNA-splicing endonuclease subunit Sen2	tRNA-intron endonuclease Sen2;	 PF01974;PF02778;	 GO:0005813;GO:0005829;GO:0005730;GO:0005654;GO:0000214;GO:0016829;GO:0003676;GO:0000213;GO:0006397;GO:0006388;GO:0000379;	  C:centrosome; C:cytosol; C:nucleolus; C:nucleoplasm; C:tRNA-intron endonuclease complex;	  F:lyase activity; F:nucleic acid binding; F:tRNA-intron endonuclease activity;	  P:mRNA processing; P:tRNA splicing, via endonucleolytic cleavage and ligation; P:tRNA-type intron splice site recognition and cleavage;
XM_040203128.1	chrXVII	1044468	1044468	chrXVII	1045492	1050094	+	XM_040203128.1	path1	Q5RC80	RNA-binding protein 39	RNA-binding motif protein 39;	 PF15519;PF00076;	 GO:0016607;GO:0003723;GO:0006397;GO:0048024;GO:0008380;	  C:nuclear speck;	  F:RNA binding;	  P:mRNA processing; P:regulation of mRNA splicing, via spliceosome; P:RNA splicing;
XM_040161196.1	chrXVIII	13683310	13683310	chrXVIII	13608801	13696867	-	XM_040161196.1	path1	Q13950 O14614 O14615 O95181	Runt-related transcription factor 2	Acute myeloid leukemia 3 protein;Core-binding factor subunit alpha-1;Oncogene AML-3;Osteoblast-specific transcription factor 2;Polyomavirus enhancer-binding protein 2 alpha A subunit;SL3-3 enhancer factor 1 alpha A subunit;SL3/AKV core-binding factor alpha A subunit;	 PF00853;PF08504;	 GO:0000785;GO:0005829;GO:0005654;GO:0005634;GO:0005524;GO:0003700;GO:0000981;GO:0000978;GO:1990837;GO:0030509;GO:0071773;GO:0002062;GO:0030097;GO:0045892;GO:0030182;GO:0001503;GO:0001649;GO:0045669;GO:0045944;GO:1901522;GO:0045893;GO:0045595;GO:0006357;GO:0060260;	  C:chromatin; C:cytosol; C:nucleoplasm; C:nucleus;	  F:ATP binding; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;	  P:BMP signaling pathway; P:cellular response to BMP stimulus; P:chondrocyte differentiation; P:hemopoiesis; P:negative regulation of transcription, DNA-templated; P:neuron differentiation; P:ossification; P:osteoblast differentiation; P:positive regulation of osteoblast differentiation; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus; P:positive regulation of transcription, DNA-templated; P:regulation of cell differentiation; P:regulation of transcription by RNA polymerase II; P:regulation of transcription initiation from RNA polymerase II promoter;
XM_040161198.1	chrXVIII	13683310	13683310	chrXVIII	13608801	13696869	-	XM_040161198.1	path1	Q13761 B1AJV5 Q12969 Q13760	Runt-related transcription factor 3	Acute myeloid leukemia 2 protein;Core-binding factor subunit alpha-3;Oncogene AML-2;Polyomavirus enhancer-binding protein 2 alpha C subunit;SL3-3 enhancer factor 1 alpha C subunit;SL3/AKV core-binding factor alpha C subunit;	 PF00853;PF08504;	 GO:0000785;GO:0016513;GO:0005737;GO:0005829;GO:0043231;GO:0005730;GO:0005654;GO:0005634;GO:0005524;GO:0003700;GO:0000981;GO:0000978;GO:0000977;GO:1990837;GO:0002062;GO:0030097;GO:0043371;GO:0045786;GO:0050680;GO:0000122;GO:0030182;GO:0001503;GO:0048935;GO:0043378;GO:0045893;GO:0006468;GO:0045595;GO:0006357;GO:0006355;GO:0071559;	  C:chromatin; C:core-binding factor complex; C:cytoplasm; C:cytosol; C:intracellular membrane-bounded organelle; C:nucleolus; C:nucleoplasm; C:nucleus;	  F:ATP binding; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;	  P:chondrocyte differentiation; P:hemopoiesis; P:negative regulation of CD4-positive, alpha-beta T cell differentiation; P:negative regulation of cell cycle; P:negative regulation of epithelial cell proliferation; P:negative regulation of transcription by RNA polymerase II; P:neuron differentiation; P:ossification; P:peripheral nervous system neuron development; P:positive regulation of CD8-positive, alpha-beta T cell differentiation; P:positive regulation of transcription, DNA-templated; P:protein phosphorylation; P:regulation of cell differentiation; P:regulation of transcription by RNA polymerase II; P:regulation of transcription, DNA-templated; P:response to transforming growth factor beta;
XM_040161199.1	chrXVIII	13693061	13693061	chrXVIII	13695635	13703482	+	XM_040161199.1	path1	Q6U736 A0AV33 Q5T5B9 Q5T886 Q7Z603 Q86SL5	Opsin-5	G-protein coupled receptor 136;G-protein coupled receptor PGR12;Neuropsin;Transmembrane protein 13;	 PF00001;	 GO:0005737;GO:0005887;GO:0005886;GO:0005502;GO:0008020;GO:0071482;GO:0071492;GO:0043153;GO:0007186;GO:1990384;GO:0007602;GO:0007604;GO:0018298;GO:0007601;	  C:cytoplasm; C:integral component of plasma membrane; C:plasma membrane;	  F:11-cis retinal binding; F:G protein-coupled photoreceptor activity;	  P:cellular response to light stimulus; P:cellular response to UV-A; P:entrainment of circadian clock by photoperiod; P:G protein-coupled receptor signaling pathway; P:hyaloid vascular plexus regression; P:phototransduction; P:phototransduction, UV; P:protein-chromophore linkage; P:visual perception;
XM_040160823.1	chrXVIII	13777410	13777410	chrXVIII	13753215	13797485	+	XM_040160823.1	path1	Q9ULI0 B9ZVQ5 Q6ZNA6 Q8N9E7	ATPase family AAA domain-containing protein 2B		 PF00004;PF17862;PF00439;	 GO:0005654;GO:0005634;GO:0005524;GO:0016887;GO:0003682;GO:0042393;GO:0070577;GO:0031936;GO:0045944;	  C:nucleoplasm; C:nucleus;	  F:ATP binding; F:ATPase activity; F:chromatin binding; F:histone binding; F:lysine-acetylated histone binding;	  P:negative regulation of chromatin silencing; P:positive regulation of transcription by RNA polymerase II;
XM_040165999.1	chrXX	15025837	15025837	chrXX	15019912	15055674	+	XM_040165999.1	path1	Q9UL36 B2RTX9 Q9UL37	Zinc finger protein 236		 PF00096;	 GO:0005634;GO:0000981;GO:0046872;GO:0000978;GO:0071333;GO:0006357;	  C:nucleus;	  F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;	  P:cellular response to glucose stimulus; P:regulation of transcription by RNA polymerase II;
XM_040165080.1	chrXX	19390057	19390057	chrXX	19332260	19425265	+	XM_040165080.1	path1	F1NTD6	Activating signal cointegrator 1 complex subunit 3		 PF00270;PF00271;PF02889;	 GO:0099053;GO:0005829;GO:0016607;GO:0005634;GO:0043138;GO:0005524;GO:0003723;GO:0008283;GO:0006307;GO:0032508;	  C:activating signal cointegrator 1 complex; C:cytosol; C:nuclear speck; C:nucleus;	  F:3'-5' DNA helicase activity; F:ATP binding; F:RNA binding;	  P:cell population proliferation; P:DNA dealkylation involved in DNA repair; P:DNA duplex unwinding;
XM_040164938.1	chrXX	19499934	19499934	chrXX	19505160	19513686	+	XM_040164938.1	path1	Q502I6	Cytochrome b5 reductase 4	Flavohemoprotein b5/b5R;cb5/cb5R;	 PF00173;PF00970;PF00175;	 GO:0005783;GO:0004128;GO:0020037;GO:0046872;GO:0006091;GO:0006801;	  C:endoplasmic reticulum;	  F:cytochrome-b5 reductase activity, acting on NAD(P)H; F:heme binding; F:metal ion binding;	  P:generation of precursor metabolites and energy; P:superoxide metabolic process;
XM_040164140.1	chrXX	19550962	19550962	chrXX	19543349	19545204	+	XM_040164140.1	path1	P79762 Q4VU46 Q4VU49 Q4VU50 Q4VU53 Q4VU54 Q4VU57 Q4VU62 Q4VU63 Q4VU66 Q9PWF8	Zona pellucida sperm-binding protein 3	Sperm receptor;Zona pellucida C protein;Zona pellucida glycoprotein 3;	 PF00100;	 GO:0045177;GO:0031012;GO:0005615;GO:0016021;GO:0005886;GO:0032190;GO:0042802;GO:0035804;GO:0007339;GO:0035803;GO:2000344;GO:0032570;GO:0033574;	  C:apical part of cell; C:extracellular matrix; C:extracellular space; C:integral component of membrane; C:plasma membrane;	  F:acrosin binding; F:identical protein binding; F:structural constituent of egg coat;	  P:binding of sperm to zona pellucida; P:egg coat formation; P:positive regulation of acrosome reaction; P:response to progesterone; P:response to testosterone;
XM_040167479.1	chrXXI	15917415	15917415	chrXXI	15902388	15945215	-	XM_040167479.1	path1	Q13634 A8K0I2 B4DHG6 Q8N5Z2	Cadherin-18	Cadherin-14;	 PF00028;PF01049;	 GO:0005912;GO:0016342;GO:0016021;GO:0005886;GO:0045296;GO:0005509;GO:0034332;GO:0016339;GO:0000902;GO:0098742;GO:0007043;GO:0007156;GO:0007275;	  C:adherens junction; C:catenin complex; C:integral component of membrane; C:plasma membrane;	  F:cadherin binding; F:calcium ion binding;	  P:adherens junction organization; P:calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules; P:cell morphogenesis; P:cell-cell adhesion via plasma-membrane adhesion molecules; P:cell-cell junction assembly; P:homophilic cell adhesion via plasma membrane adhesion molecules; P:multicellular organism development;
XM_040167583.1	chrXXI	16079787	16079787	chrXXI	16040433	16110337	-	XM_040167583.1	path1	P55289 B2RBT1 B7Z2U6 Q86UD2	Cadherin-12	Brain cadherin;Neural type cadherin 2;	 PF00028;PF01049;	 GO:0005912;GO:0016342;GO:0016021;GO:0005886;GO:0045296;GO:0005509;GO:0034332;GO:0016339;GO:0000902;GO:0098742;GO:0007043;GO:0007156;GO:0007275;	  C:adherens junction; C:catenin complex; C:integral component of membrane; C:plasma membrane;	  F:cadherin binding; F:calcium ion binding;	  P:adherens junction organization; P:calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules; P:cell morphogenesis; P:cell-cell adhesion via plasma-membrane adhesion molecules; P:cell-cell junction assembly; P:homophilic cell adhesion via plasma membrane adhesion molecules; P:multicellular organism development;
